We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

83 hedge funds and large institutions have $286M invested in La Jolla Pharmaceutical Company in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

6% more funds holding

Funds holding: 78 → 83 (+5)

4% more call options, than puts

Call options by funds: $389K | Put options by funds: $374K

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

57% less capital invested

Capital invested by funds: $670M → $286M (-$384M)

Holders
83
Holders Change
+5
Holders Change %
+6.41%
% of All Funds
1.85%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
18
Increased
22
Reduced
24
Closed
13
Calls
$389K
Puts
$374K
Net Calls
+$15K
Net Calls Change
-$4.84M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$7.38M
2
FI
Fosun International
China
+$4.64M
3
HCMT
Highland Capital Management (Texas)
Texas
+$1.91M
4
SIM
Spark Investment Management
New York
+$1.85M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$1.66M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$18.7M
2
RI
RTW Investments
New York
-$14M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.5M
4
AG
Artal Group
Luxembourg
-$4.03M
5
TCM
Tang Capital Management
California
-$3.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$1.08M +$124K +8,229 +8%
AllianceBernstein
27
AllianceBernstein
Tennessee
$1.08M +$1.39M +92,148 +413%
Citadel Advisors
28
Citadel Advisors
Florida
$1M +$1.6M +106,273 New
Allianz Asset Management
29
Allianz Asset Management
Germany
$811K -$54.3K -3,606 -4%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$803K -$87.3K -5,799 -6%
Marshall Wace
31
Marshall Wace
United Kingdom
$685K +$1.09M +72,638 New
Goldman Sachs
32
Goldman Sachs
New York
$623K +$127K +8,416 +15%
Morgan Stanley
33
Morgan Stanley
New York
$563K +$251K +16,707 +39%
Bank of America
34
Bank of America
North Carolina
$527K +$80.5K +5,353 +11%
OTPPB
35
Ontario Teachers' Pension Plan Board
Ontario, Canada
$524K +$836K +55,587 New
Deutsche Bank
36
Deutsche Bank
Germany
$450K -$1.13M -75,034 -61%
TCIM
37
TIAA CREF Investment Management
New York
$398K -$6.18K -411 -1%
ERSOT
38
Employees Retirement System of Texas
Texas
$387K – – –
Barclays
39
Barclays
United Kingdom
$386K -$1.52M -100,899 -71%
TA
40
Teachers Advisors
New York
$374K – – –
GCP
41
GSA Capital Partners
United Kingdom
$361K +$576K +38,292 New
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$331K – – –
ORI
43
Oak Ridge Investments
Illinois
$330K -$2.02M -134,062 -79%
Swiss National Bank
44
Swiss National Bank
Switzerland
$328K +$25.6K +1,700 +5%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$317K +$11.7K +780 +2%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$301K – – –
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$283K +$452K +30,050 New
QSS
48
Quantitative Systematic Strategies
Florida
$261K +$417K +27,725 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$260K +$136K +9,064 +49%
Squarepoint
50
Squarepoint
New York
$237K -$188K -12,485 -33%
1
2
3 4

LJPC Hedge Fund Activity: Q4 2018 in Review

83 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q4 2018, worth a combined $286M — down 57% from $670M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new LJPC positions and 13 closed out — a net gain of 5 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $7.38M. The largest seller was State Street, cutting an estimated $18.7M.

  • 83 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q4 2018, up from 78 in Q3 2018.
  • Funds reported $286M of La Jolla Pharmaceutical Company stock for Q4 2018, down 57% quarter-over-quarter.
  • 18 funds opened new La Jolla Pharmaceutical Company positions in Q4 2018 and 13 closed out, a net change of +5 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q4 2018 was Millennium Management, an estimated $7.38M added.
  • The largest La Jolla Pharmaceutical Company seller in Q4 2018 was State Street, an estimated $18.7M sold.

Based on aggregated 13F filings for Q4 2018.